11 January 2012
Novartis temporarily suspends production of Interceptor, Sentinel
Novartis Animal Health has ceased production of Interceptor, Sentinel and several other drugs manufactured in its plant in Lincoln, Neb., while the facility undergoes "process and compliance improvement activities," a spokesman for the company confirmed today.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment